Charlotte Palominos

Ms. Charlotte Palominos

Faculty of Medicine, University of Chile
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MCMiguel Cordova-Delgado
Miguel Cordova-Delgado
SFSebastián Fuentes-Retamal
Sebastián Fuentes-Retamal
CPCharlotte Palominos
Charlotte Palominos
CLCamila López-Torres
Camila López-Torres
DGDaniela Guzmán-Rivera
Daniela Guzmán-Rivera
FUFelix Urra
Felix Urra
Since breast cancer (BC) cells are dependent on mitochondrial bioenergetics for promoting proliferation, survival, and metastasis, mitochondria highlight as an important target for anticancer drug discovery. FRI-1, methyl 1, 3-dimethyl-5, 8-dioxo-5, 8-dihydro-4-isoquinolinecarboxylate, was previously described as a selective cytotoxic compound on cancer cell lines, however, details on the mechanism of action remain unknown. In this work, we describe that FRI-1 inhibits mitochondrial bioenergetics, producing apoptosis in MCF7 and MDA-MB-231 BC cell lines. FRI-1 decreases the maximal oxygen consumption rate (OCR), Δψm, NADH, and ATP levels, with a notable increase of mitochondrial reactive oxygen species (ROS) production, promoting AMPK activation with pro-survival effects. Moreover, FRI-1 inhibits the metabolic remodeling to glycolysis induced by oligomycin. In isolated tumoral mitochondria, FRI-1 increases Complex I and III-dependent OCR state 2, and this is sensitive to rotenone and antimycin A inhibitor additions, suggesting a redox cycling event. Remarkably, α-ketoglutarate and lipoic acid supplementation reversed and promoted, respectively, the FRI-1-induced apoptosis, suggesting that mitochondrial redox disruption affects 2-oxoglutarate dehydrogenase (OGDH) activity, and this is involved in their anticancer mechanism. Consistent with this, the combination of FRI-1 and CPI-613, a dual inhibitor of redox-sensible tricarboxylic acid (TCA) cycle enzymes PDH and OGDH, produced extensive BC cell death. Taken together, our results suggest that FRI-1 exhibits anticancer effects through inhibition of mitochondrial bioenergetics by redox disruption in BC cells.

6 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GSGuillermo Schmeda-Hirschmann
Guillermo Schmeda-Hirschmann
ABAlberto Burgos-Edwards
Alberto Burgos-Edwards
AAAntonieta Rojas de Arias
Antonieta Rojas de Arias
CLCamila López-Torres
Camila López-Torres
CPCharlotte Palominos
Charlotte Palominos
FUFelix Urra
Felix Urra